Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Professor in Population Health Sciences
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993


Alexander, B. D., S. M. Palmer, V. F. Tapson, R. D. Davis, and L. B. Reller. “Bacteremia and fungemia in lung transplant recipients at Duke University Medical Center.” American Journal of Respiratory and Critical Care Medicine 159, no. 3 (March 1, 1999): A738–A738.


Wood, K. A., S. M. Palmer, J. Govert, M. A. Baz, M. P. Steele, R. D. Davis, T. A. D’Amico, and V. F. Tapson. “Outcomes of lung transplant recipients with respiratory failure requiring mechanical ventilation.” In American Journal of Respiratory and Critical Care Medicine, 159:A54–A54. AMER LUNG ASSOC, 1999.


Palmer, S. M., H. P. McAdams, J. R. MacFall, L. Donnelly, R. D. Davis, and V. F. Tapson. “Hyperpolarized helium-3 magnetic resonance imaging of bronchiolitis obliterans syndrome in lung transplant recipients.” American Journal of Respiratory and Critical Care Medicine 159, no. 3 (March 1, 1999): A276–A276.


McAdams, H. P., S. M. Palmer, J. J. Erasmus, E. F. Patz, J. E. Connolly, P. C. Goodman, D. M. Delong, and V. F. Tapson. “Bronchial anastomotic complications in lung transplant recipients: virtual bronchoscopy for noninvasive assessment.” Radiology 209, no. 3 (December 1998): 689–95.

Full Text

Marom, E. M., H. F. McAdams, J. J. Erasmus, S. M. Palmer, T. A. Sporn, and V. F. Tapson. “Value of chest CT in the pretransplant evaluation of patients with cystic fibrosis.” In Radiology, 209P:488–488. RADIOLOGICAL SOC NORTH AMER, 1998.


Palmer, S. M., and V. F. Tapson. “Infection in organ-transplant recipients.” N Engl J Med 339, no. 17 (October 22, 1998): 1245–46.


Mariencheck, W. I., V. F. Tapson, and S. M. Palmer. “Alterations of pulmonary Surfactant Protein A (SP-A) in bronchoalveolar lavage of human lung transplant recipients.” Chest 114, no. 4 SUPPL. (October 1, 1998).


Palmer, S. M., J. R. Perfect, D. N. Howell, C. M. Lawrence, A. P. Miralles, R. D. Davis, and V. F. Tapson. “Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents.” J Heart Lung Transplant 17, no. 10 (October 1998): 1029–33.


Malchow, S. C., H. P. McAdams, S. M. Palmer, V. F. Tapson, and C. E. Putman. “Does hyperexpansion of the native lung adversely affect outcome after single lung transplantation for emphysema? Preliminary findings.” Acad Radiol 5, no. 10 (October 1998): 688–93.

Full Text